| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyBiologicalProcess | post-translational protein targeting to endoplasmic reticulum membrane | 3.99e-05 | 21 | 66 | 3 | GO:0006620 | |
| GeneOntologyBiologicalProcess | Rac protein signal transduction | 4.07e-05 | 60 | 66 | 4 | GO:0016601 | |
| GeneOntologyCellularComponent | kainate selective glutamate receptor complex | 1.60e-04 | 6 | 69 | 2 | GO:0032983 | |
| Domain | Cezanne-2 | 1.35e-05 | 2 | 69 | 2 | IPR033477 | |
| Domain | ERM_C_dom | 8.03e-05 | 4 | 69 | 2 | IPR011259 | |
| Domain | ERM | 8.03e-05 | 4 | 69 | 2 | PF00769 | |
| Domain | ERM | 8.03e-05 | 4 | 69 | 2 | IPR011174 | |
| Domain | Znf_A20 | 2.79e-04 | 7 | 69 | 2 | IPR002653 | |
| Domain | ZF_A20 | 2.79e-04 | 7 | 69 | 2 | PS51036 | |
| Domain | zf-A20 | 2.79e-04 | 7 | 69 | 2 | PF01754 | |
| Domain | Moesin_tail | 2.79e-04 | 7 | 69 | 2 | IPR008954 | |
| Domain | ZnF_A20 | 2.79e-04 | 7 | 69 | 2 | SM00259 | |
| Domain | OTU | 1.02e-03 | 13 | 69 | 2 | PF02338 | |
| Domain | OTU | 1.37e-03 | 15 | 69 | 2 | PS50802 | |
| Domain | OTU_dom | 1.37e-03 | 15 | 69 | 2 | IPR003323 | |
| Domain | - | 1.43e-03 | 333 | 69 | 6 | 2.130.10.10 | |
| Domain | WD40/YVTN_repeat-like_dom | 1.48e-03 | 335 | 69 | 6 | IPR015943 | |
| Domain | Gal_mutarotase_SF_dom | 1.76e-03 | 17 | 69 | 2 | IPR011013 | |
| Domain | CH | 1.79e-03 | 65 | 69 | 3 | SM00033 | |
| Domain | Iontro_rcpt | 1.98e-03 | 18 | 69 | 2 | IPR001320 | |
| Domain | Lig_chan-Glu_bd | 1.98e-03 | 18 | 69 | 2 | PF10613 | |
| Domain | Iono_rcpt_met | 1.98e-03 | 18 | 69 | 2 | IPR001508 | |
| Domain | Glu/Gly-bd | 1.98e-03 | 18 | 69 | 2 | IPR019594 | |
| Domain | Lig_chan-Glu_bd | 1.98e-03 | 18 | 69 | 2 | SM00918 | |
| Domain | Lig_chan | 1.98e-03 | 18 | 69 | 2 | PF00060 | |
| Domain | PBPe | 1.98e-03 | 18 | 69 | 2 | SM00079 | |
| Domain | CH | 2.21e-03 | 70 | 69 | 3 | PF00307 | |
| Domain | - | 2.30e-03 | 71 | 69 | 3 | 1.10.418.10 | |
| Domain | CH | 2.49e-03 | 73 | 69 | 3 | PS50021 | |
| Domain | WD40 | 2.69e-03 | 259 | 69 | 5 | PF00400 | |
| Domain | CH-domain | 2.69e-03 | 75 | 69 | 3 | IPR001715 | |
| Domain | Ez/rad/moesin-like | 2.70e-03 | 21 | 69 | 2 | IPR000798 | |
| Domain | WD40 | 3.12e-03 | 268 | 69 | 5 | SM00320 | |
| Domain | Actinin_actin-bd_CS | 3.24e-03 | 23 | 69 | 2 | IPR001589 | |
| Domain | Spectrin | 3.24e-03 | 23 | 69 | 2 | PF00435 | |
| Domain | ACTININ_2 | 3.24e-03 | 23 | 69 | 2 | PS00020 | |
| Domain | ACTININ_1 | 3.24e-03 | 23 | 69 | 2 | PS00019 | |
| Domain | zf-CCHC | 3.24e-03 | 23 | 69 | 2 | PF00098 | |
| Domain | WD40_repeat | 3.32e-03 | 272 | 69 | 5 | IPR001680 | |
| Domain | FERM_CS | 3.52e-03 | 24 | 69 | 2 | IPR019747 | |
| Domain | WD_REPEATS_1 | 3.65e-03 | 278 | 69 | 5 | PS00678 | |
| Domain | WD_REPEATS_2 | 3.70e-03 | 279 | 69 | 5 | PS50082 | |
| Domain | WD_REPEATS_REGION | 3.70e-03 | 279 | 69 | 5 | PS50294 | |
| Domain | HormR | 3.82e-03 | 25 | 69 | 2 | SM00008 | |
| Domain | EF_Hand_1_Ca_BS | 4.01e-03 | 175 | 69 | 4 | IPR018247 | |
| Domain | FERM_C | 4.13e-03 | 26 | 69 | 2 | PF09380 | |
| Domain | FERM_C | 4.45e-03 | 27 | 69 | 2 | SM01196 | |
| Domain | FERM_PH-like_C | 4.45e-03 | 27 | 69 | 2 | IPR018980 | |
| Domain | HRM | 4.78e-03 | 28 | 69 | 2 | PF02793 | |
| Domain | WD40_repeat_dom | 4.82e-03 | 297 | 69 | 5 | IPR017986 | |
| Domain | Spectrin_repeat | 5.12e-03 | 29 | 69 | 2 | IPR002017 | |
| Domain | Spectrin/alpha-actinin | 6.21e-03 | 32 | 69 | 2 | IPR018159 | |
| Domain | SPEC | 6.21e-03 | 32 | 69 | 2 | SM00150 | |
| Domain | FERM_N | 6.60e-03 | 33 | 69 | 2 | PF09379 | |
| Domain | FERM_N | 6.60e-03 | 33 | 69 | 2 | IPR018979 | |
| Domain | EF_HAND_1 | 6.87e-03 | 204 | 69 | 4 | PS00018 | |
| Domain | GPCR_2_secretin-like_CS | 6.99e-03 | 34 | 69 | 2 | IPR017983 | |
| Pubmed | 4.11e-06 | 2 | 71 | 2 | 22203159 | ||
| Pubmed | High-affinity kainate receptor subunits are necessary for ionotropic but not metabotropic signaling. | 4.11e-06 | 2 | 71 | 2 | 19778510 | |
| Pubmed | Epithelial organization and cyst lumen expansion require efficient Sec13-Sec31-driven secretion. | 4.11e-06 | 2 | 71 | 2 | 22331354 | |
| Pubmed | 4.11e-06 | 2 | 71 | 2 | 16407955 | ||
| Pubmed | Subunit-specific desensitization of heteromeric kainate receptors. | 4.11e-06 | 2 | 71 | 2 | 20026616 | |
| Pubmed | 1.23e-05 | 3 | 71 | 2 | 10788476 | ||
| Pubmed | 1.23e-05 | 3 | 71 | 2 | 1429901 | ||
| Pubmed | 1.23e-05 | 3 | 71 | 2 | 8479753 | ||
| Pubmed | ERM Proteins at the Crossroad of Leukocyte Polarization, Migration and Intercellular Adhesion. | 1.23e-05 | 3 | 71 | 2 | 32098334 | |
| Pubmed | 1.23e-05 | 3 | 71 | 2 | 18261459 | ||
| Pubmed | 1.23e-05 | 3 | 71 | 2 | 21659656 | ||
| Pubmed | 1.23e-05 | 3 | 71 | 2 | 19064715 | ||
| Pubmed | Activation of PKC induces leukocyte adhesion by the dephosphorylation of ERM. | 1.23e-05 | 3 | 71 | 2 | 31843195 | |
| Pubmed | 1.23e-05 | 3 | 71 | 2 | 18295815 | ||
| Pubmed | Dmoesin controls actin-based cell shape and polarity during Drosophila melanogaster oogenesis. | 1.23e-05 | 3 | 71 | 2 | 12360288 | |
| Pubmed | 1.23e-05 | 3 | 71 | 2 | 16325263 | ||
| Pubmed | 1.23e-05 | 3 | 71 | 2 | 21864676 | ||
| Pubmed | 1.23e-05 | 3 | 71 | 2 | 14613898 | ||
| Pubmed | Activation of Ras requires the ERM-dependent link of actin to the plasma membrane. | 1.23e-05 | 3 | 71 | 2 | 22132106 | |
| Pubmed | Dynamics and function of ERM proteins during cytokinesis in human cells. | 1.23e-05 | 3 | 71 | 2 | 28889652 | |
| Pubmed | 1.23e-05 | 3 | 71 | 2 | 21278069 | ||
| Pubmed | Inhibition of cell adhesion by phosphorylated Ezrin/Radixin/Moesin. | 1.23e-05 | 3 | 71 | 2 | 26555866 | |
| Pubmed | Control of adipogenesis by ezrin, radixin and moesin-dependent biomechanics remodeling. | 1.23e-05 | 3 | 71 | 2 | 23116763 | |
| Pubmed | 1.23e-05 | 3 | 71 | 2 | 21451358 | ||
| Pubmed | Human ezrin-moesin-radixin proteins modulate hepatitis C virus infection. | 1.23e-05 | 3 | 71 | 2 | 23703860 | |
| Pubmed | Ezrin-radixin-moesin family proteins are involved in parvovirus replication and spreading. | 1.23e-05 | 3 | 71 | 2 | 19321616 | |
| Pubmed | Pseudomonas aeruginosa ExoS ADP-ribosyltransferase inhibits ERM phosphorylation. | 1.23e-05 | 3 | 71 | 2 | 16889625 | |
| Pubmed | 1.23e-05 | 3 | 71 | 2 | 29906485 | ||
| Pubmed | 1.23e-05 | 3 | 71 | 2 | 20679347 | ||
| Pubmed | Differential expression and distribution of ezrin, radixin and moesin in human natural killer cells. | 1.23e-05 | 3 | 71 | 2 | 12385025 | |
| Pubmed | Are ERM (ezrin/radixin/moesin) proteins targets for autoantibodies in demyelinating neuropathies? | 1.23e-05 | 3 | 71 | 2 | 25286001 | |
| Pubmed | Nuclear ERM (ezrin, radixin, moesin) proteins: regulation by cell density and nuclear import. | 1.23e-05 | 3 | 71 | 2 | 15149851 | |
| Pubmed | 1.23e-05 | 3 | 71 | 2 | 17977945 | ||
| Pubmed | 1.23e-05 | 3 | 71 | 2 | 15252013 | ||
| Pubmed | Ezrin/radixin/moesin proteins differentially regulate endothelial hyperpermeability after thrombin. | 1.23e-05 | 3 | 71 | 2 | 23729486 | |
| Pubmed | Effect of knockdown of ezrin, radixin, and moesin on P-glycoprotein function in HepG2 cells. | 1.23e-05 | 3 | 71 | 2 | 21837648 | |
| Pubmed | 1.23e-05 | 3 | 71 | 2 | 32160548 | ||
| Pubmed | 1.23e-05 | 3 | 71 | 2 | 12734202 | ||
| Pubmed | ERM stable knockdown by siRNA reduced in vitro migration and invasion of human SGC-7901 cells. | 1.23e-05 | 3 | 71 | 2 | 21352885 | |
| Pubmed | Ezrin and moesin function together to promote T cell activation. | 1.23e-05 | 3 | 71 | 2 | 19124745 | |
| Pubmed | Effect of N-(3-phenyl-2-propenyl)-1-deoxynojirimycin on the lectin binding to HIV-1 glycoproteins. | 1.82e-05 | 25 | 71 | 3 | 2283726 | |
| Pubmed | 1.83e-05 | 76 | 71 | 4 | 27542412 | ||
| Pubmed | 2.05e-05 | 26 | 71 | 3 | 8218172 | ||
| Pubmed | 2.46e-05 | 4 | 71 | 2 | 17237445 | ||
| Pubmed | The ERM proteins interact with the HOPS complex to regulate the maturation of endosomes. | 2.46e-05 | 4 | 71 | 2 | 21148287 | |
| Pubmed | Structural basis for cargo regulation of COPII coat assembly. | 2.46e-05 | 4 | 71 | 2 | 18692470 | |
| Pubmed | 2.46e-05 | 4 | 71 | 2 | 18713835 | ||
| Pubmed | 2.46e-05 | 4 | 71 | 2 | 18941185 | ||
| Pubmed | Leucine-rich repeat kinase 2 regulates Sec16A at ER exit sites to allow ER-Golgi export. | 2.46e-05 | 4 | 71 | 2 | 25201882 | |
| Pubmed | 2.46e-05 | 4 | 71 | 2 | 15178693 | ||
| Pubmed | Functional binding interaction identified between the axonal CAM L1 and members of the ERM family. | 2.46e-05 | 4 | 71 | 2 | 12070130 | |
| Pubmed | CPI-17 drives oncogenic Ras signaling in human melanomas via Ezrin-Radixin-Moesin family proteins. | 2.46e-05 | 4 | 71 | 2 | 27793041 | |
| Pubmed | 2.46e-05 | 4 | 71 | 2 | 15096511 | ||
| Pubmed | Distribution of kainate receptor subunits at hippocampal mossy fiber synapses. | 2.46e-05 | 4 | 71 | 2 | 12954862 | |
| Pubmed | 2.46e-05 | 4 | 71 | 2 | 20660156 | ||
| Pubmed | 2.46e-05 | 4 | 71 | 2 | 19129194 | ||
| Pubmed | 2.46e-05 | 4 | 71 | 2 | 15818415 | ||
| Pubmed | 2.46e-05 | 4 | 71 | 2 | 9430655 | ||
| Pubmed | 2.46e-05 | 4 | 71 | 2 | 31018575 | ||
| Pubmed | 2.46e-05 | 4 | 71 | 2 | 24760896 | ||
| Pubmed | 2.46e-05 | 4 | 71 | 2 | 19890007 | ||
| Pubmed | Proteomic profiling in pancreatic cancer with and without lymph node metastasis. | 2.46e-05 | 4 | 71 | 2 | 19152423 | |
| Pubmed | 2.46e-05 | 4 | 71 | 2 | 28302370 | ||
| Pubmed | 2.46e-05 | 4 | 71 | 2 | 22685202 | ||
| Pubmed | 2.46e-05 | 4 | 71 | 2 | 19255442 | ||
| Pubmed | 2.46e-05 | 4 | 71 | 2 | 9890997 | ||
| Pubmed | Spatial regulation of cyclic AMP-Epac1 signaling in cell adhesion by ERM proteins. | 2.46e-05 | 4 | 71 | 2 | 20855527 | |
| Pubmed | STAM adaptor proteins interact with COPII complexes and function in ER-to-Golgi trafficking. | 2.46e-05 | 4 | 71 | 2 | 19054391 | |
| Pubmed | 2.46e-05 | 4 | 71 | 2 | 21289089 | ||
| Pubmed | Developmental expression patterns of kainate receptors in the mouse spinal cord. | 4.09e-05 | 5 | 71 | 2 | 23076118 | |
| Pubmed | 4.09e-05 | 5 | 71 | 2 | 21278261 | ||
| Pubmed | Activated ERM protein plays a critical role in drug resistance of MOLT4 cells induced by CCL25. | 4.09e-05 | 5 | 71 | 2 | 23326330 | |
| Pubmed | 4.09e-05 | 5 | 71 | 2 | 19830727 | ||
| Pubmed | CCDC102B functions in centrosome linker assembly and centrosome cohesion. | 4.09e-05 | 5 | 71 | 2 | 30404835 | |
| Pubmed | 4.09e-05 | 5 | 71 | 2 | 25575591 | ||
| Pubmed | 4.09e-05 | 5 | 71 | 2 | 26448475 | ||
| Pubmed | 4.09e-05 | 5 | 71 | 2 | 8288598 | ||
| Pubmed | Kainate receptors: pharmacology, function and therapeutic potential. | 4.09e-05 | 5 | 71 | 2 | 18793656 | |
| Pubmed | 4.09e-05 | 5 | 71 | 2 | 16957052 | ||
| Pubmed | 4.09e-05 | 5 | 71 | 2 | 28228252 | ||
| Pubmed | 4.09e-05 | 5 | 71 | 2 | 12223554 | ||
| Pubmed | A Pak1-PP2A-ERM signaling axis mediates F-actin rearrangement and degranulation in mast cells. | 4.09e-05 | 5 | 71 | 2 | 23063725 | |
| Pubmed | 4.09e-05 | 5 | 71 | 2 | 22891241 | ||
| Pubmed | The TSC1 tumour suppressor hamartin regulates cell adhesion through ERM proteins and the GTPase Rho. | 4.09e-05 | 5 | 71 | 2 | 10806479 | |
| Pubmed | In vitro reconstitution of ER-stress induced ATF6 transport in COPII vesicles. | 4.09e-05 | 5 | 71 | 2 | 19822759 | |
| Pubmed | 4.09e-05 | 5 | 71 | 2 | 18358623 | ||
| Pubmed | 4.09e-05 | 5 | 71 | 2 | 23019340 | ||
| Pubmed | 4.09e-05 | 5 | 71 | 2 | 9464455 | ||
| Pubmed | Development of laminar distributions of kainate receptors in the somatosensory cortex of mice. | 4.09e-05 | 5 | 71 | 2 | 9593973 | |
| Pubmed | Preferential assembly of heteromeric kainate and AMPA receptor amino terminal domains. | 4.09e-05 | 5 | 71 | 2 | 29058671 | |
| Pubmed | A novel role for BRCA1 in regulating breast cancer cell spreading and motility. | 4.09e-05 | 5 | 71 | 2 | 21282464 | |
| Pubmed | KIAA0408 SLC25A24 GALE SUPT6H SPATA18 TERF1 GSC HERC5 STEAP1 | 4.86e-05 | 832 | 71 | 9 | 36724073 | |
| Pubmed | Diversification of stem cell molecular repertoire by alternative splicing. | 5.09e-05 | 35 | 71 | 3 | 16183747 | |
| Pubmed | Intracellular mannose binding lectin mediates subcellular trafficking of HIV-1 gp120 in neurons. | 6.13e-05 | 6 | 71 | 2 | 24825317 | |
| Pubmed | 6.13e-05 | 6 | 71 | 2 | 17349711 | ||
| Pubmed | 6.13e-05 | 6 | 71 | 2 | 17515952 | ||
| Pubmed | N-glycan content modulates kainate receptor functional properties. | 6.13e-05 | 6 | 71 | 2 | 28714086 | |
| Pubmed | 6.13e-05 | 6 | 71 | 2 | 26209696 | ||
| Pubmed | 6.13e-05 | 6 | 71 | 2 | 12226091 | ||
| Pubmed | 6.13e-05 | 6 | 71 | 2 | 23229862 | ||
| Cytoband | 8q21.11 | 8.68e-04 | 28 | 71 | 2 | 8q21.11 | |
| GeneFamily | Glutamate ionotropic receptor kainate type subunits | 6.58e-05 | 5 | 47 | 2 | 1199 | |
| GeneFamily | WD repeat domain containing | 5.74e-04 | 262 | 47 | 5 | 362 | |
| GeneFamily | OTU domain containing | 8.77e-04 | 17 | 47 | 2 | 669 | |
| GeneFamily | EF-hand domain containing | 2.48e-03 | 219 | 47 | 4 | 863 | |
| GeneFamily | Ankyrin repeat domain containing|FERM domain containing | 7.48e-03 | 50 | 47 | 2 | 1293 | |
| GeneFamily | GATA zinc finger domain containing|Myb/SANT domain containing | 8.38e-03 | 53 | 47 | 2 | 532 | |
| ToppCell | Primary_Visual_cortex_(V1C)-Neuronal-Glutamatergic_Excit-Glut_A_(CT)-Glut_CT_L6_FEZF2-Exc_L6_FEZF2_VWA2|Primary_Visual_cortex_(V1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 4.27e-07 | 182 | 70 | 6 | 72e65a23cd36085bc880087d3cae92395de918a1 | |
| ToppCell | Primary_Visual_cortex_(V1C)-Neuronal-Glutamatergic_Excit-Glut_A_(CT)-Glut_CT_L6_FEZF2|Primary_Visual_cortex_(V1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 4.27e-07 | 182 | 70 | 6 | 05c167158815bf25d509df59ab386e1990712765 | |
| ToppCell | COPD-Endothelial-VE_Venous|Endothelial / Disease state, Lineage and Cell class | 9.25e-06 | 179 | 70 | 5 | e816dd846a6918ec143b57a380c3a47ed073b66e | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Neuronal-Inh_GABAergic-i_Gaba_2-GABA_VIP_1-Inh_L1_SST_CXCL14|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 9.51e-06 | 180 | 70 | 5 | b6efdb4d319ef6f87f559acd974e5a71b06a2322 | |
| ToppCell | ASK454-Epithelial|ASK454 / Donor, Lineage and Cell class of Lung cells from Dropseq | 1.00e-05 | 182 | 70 | 5 | ab15316cff989b61ff397a866d7ca8b49c13e981 | |
| ToppCell | LPS-IL1RA+antiTNF-Epithelial_alveolar-AT_2|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.00e-05 | 182 | 70 | 5 | 17ed11a7ea366dd3106400511d5e628d3f1a9c3e | |
| ToppCell | LPS-IL1RA+antiTNF-Epithelial_alveolar-AT_2-AT2_Progenitor|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.06e-05 | 184 | 70 | 5 | d0c212a8fbaad24597a84018442b25c61c17ea58 | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Neuronal-Inh_GABAergic-i_Gaba_2-GABA_VIP_1|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.09e-05 | 185 | 70 | 5 | 08fad1e3c3cc5f1c3eb6629a49c094b628e75a92 | |
| ToppCell | LPS-IL1RA+antiTNF-Stromal_mesenchymal-Lung_smooth_muscle-MatrixFB_->_Myofibroblast|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.09e-05 | 185 | 70 | 5 | 3b2dfc8f4c87be516265dbecfc251276034d0efd | |
| ToppCell | COVID-19_Moderate-NK_activated|World / disease group, cell group and cell class | 1.11e-05 | 186 | 70 | 5 | ff8f32f69516bf785224fa12f8139a95359b0279 | |
| ToppCell | LPS_IL1RA_TNF|World / Treatment groups by lineage, cell group, cell type | 1.47e-05 | 197 | 70 | 5 | 0a6550dce156fc81f15b1e7830d331ca50d87d06 | |
| ToppCell | IPF-Stromal-Myofibroblast|Stromal / Disease state, Lineage and Cell class | 1.47e-05 | 197 | 70 | 5 | f304d42fc4936fe20996e07c8dccc698a6e5e5ef | |
| ToppCell | Neuronal-Inhibitory-iA|Neuronal / cells hierarchy compared to all cells using T-Statistic | 1.58e-05 | 200 | 70 | 5 | 5ef4a3dc18a44292184a59ced916183c0699b01e | |
| ToppCell | PND01-Epithelial-Epithelial_Airway-Ciliated/Deuterosomal-Deuterosomal|PND01 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 9.41e-05 | 151 | 70 | 4 | e335dad89e0a44cdd302b9653154ba5d1ee5fe1a | |
| ToppCell | PND01-Epithelial-Epithelial_Airway-Ciliated/Deuterosomal-Deuterosomal-Deuterosomal_mature|PND01 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 9.41e-05 | 151 | 70 | 4 | 633ed52dd3b4cf1e87432cf0a1ca187d7b204e83 | |
| ToppCell | Hippocampus-Macroglia-CSF_related|Hippocampus / BrainAtlas - Mouse McCarroll V32 | 9.65e-05 | 152 | 70 | 4 | c2b6cc41546cbd46b9ea5d28a7c66f6330a27df2 | |
| ToppCell | saliva-Mild-Moderate_progression_d12-25-Myeloid-Granulocytic-Neutrophil-Neu_c6-FGF23|Mild-Moderate_progression_d12-25 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 9.65e-05 | 152 | 70 | 4 | 0652ee3443e6fbb679d2c4f326239ae7c803f924 | |
| ToppCell | COVID-19-kidney-Technical/muscle_(Mes)|kidney / Disease (COVID-19 only), tissue and cell type | 1.15e-04 | 159 | 70 | 4 | 5335cbcdeaf2bbd0268bbfe0e45c8c0d288e640d | |
| ToppCell | 3'_v3-GI_small-bowel-Lymphocytic_NK-NK_CD16|GI_small-bowel / Manually curated celltypes from each tissue | 1.55e-04 | 172 | 70 | 4 | 701de463f85aaad3a4b36a0d5fbc416406620089 | |
| ToppCell | (0)_Normal/No_Treatment-(4)_COL2.3+_osteoblasts|(0)_Normal/No_Treatment / Stress and Cell class | 1.59e-04 | 173 | 70 | 4 | c2a0f674681836b5a868c13f67caa7d555ef6519 | |
| ToppCell | PCW_10-12-Epithelial-Epithelial_ciliated|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung | 1.62e-04 | 174 | 70 | 4 | b8d1c556290d188f56aeefc17f03119686945fe7 | |
| ToppCell | PND03-Epithelial-Epithelial_Airway-Ciliated/Deuterosomal-Deuterosomal|PND03 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.62e-04 | 174 | 70 | 4 | 179a52d77899a929396b98d4ab2c270dd2ec708e | |
| ToppCell | PCW_10-12-Epithelial-Epithelial_ciliated-epi_ciliated_(14)|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung | 1.62e-04 | 174 | 70 | 4 | 00cf27bc23af1472a507be31fba6245a8fdd901b | |
| ToppCell | PND03-Epithelial-Epithelial_Airway-Ciliated/Deuterosomal-Deuterosomal-Deuterosomal_mature|PND03 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.62e-04 | 174 | 70 | 4 | 9165a1094d345328e58962f4b2a20334c3e93ead | |
| ToppCell | PCW_13-14-Epithelial-Epithelial_ciliated|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung | 1.66e-04 | 175 | 70 | 4 | b1369d2b74f461e6822d0c33e9b50fe0dfbceb54 | |
| ToppCell | PCW_13-14-Epithelial-Epithelial_ciliated-epi_ciliated_(14)|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung | 1.66e-04 | 175 | 70 | 4 | c82ec6deb6ccdd991a69a62b6d62d5b14c803d7a | |
| ToppCell | facs-Marrow-KLS-18m-Lymphocytic-early_pro_B_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.70e-04 | 176 | 70 | 4 | 7292e014b8f697f0c2e9f47c48333de95cb44a69 | |
| ToppCell | PND10-Epithelial-Epithelial_Airway-Ciliated/Deuterosomal-Deuterosomal|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.70e-04 | 176 | 70 | 4 | d6d7e4e937d49a5c0d16322c8dd3bf9e97eb8732 | |
| ToppCell | facs-Marrow-KLS-18m-Lymphocytic-early_pro-B_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.70e-04 | 176 | 70 | 4 | 88ca2f83d8301633232735f39b0683efe49d0b86 | |
| ToppCell | PND10-Epithelial-Epithelial_Airway-Ciliated/Deuterosomal-Deuterosomal-Deuterosomal_mature|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.70e-04 | 176 | 70 | 4 | c03d80df2550c0d2b0452326480d6bf21d20fdd2 | |
| ToppCell | 3'_v3-GI_small-bowel-Lymphocytic_NK|GI_small-bowel / Manually curated celltypes from each tissue | 1.81e-04 | 179 | 70 | 4 | 535bdfdd990ba9ee3edc8f3ad15297f8fb5a266e | |
| ToppCell | LPS-IL1RA-Stromal_mesenchymal-Lung_smooth_muscle-MatrixFB_->_Myofibroblast|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.81e-04 | 179 | 70 | 4 | 02c90d8306016365ed811f0c63cfb3ac7b85464c | |
| ToppCell | facs-SCAT|facs / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.85e-04 | 180 | 70 | 4 | 6c70b6b7480507fa94625013222ad338ee7dd1d9 | |
| ToppCell | facs-GAT-Fat-3m-Epithelial-epithelial_cell|GAT / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.89e-04 | 181 | 70 | 4 | e97cbaafb93fdbee8e3cf4a06e6bcf121d941403 | |
| ToppCell | COVID-19-Heart-Pericyte|COVID-19 / Disease (COVID-19 only), tissue and cell type | 1.89e-04 | 181 | 70 | 4 | 33cac65ed1ea5e7bd72250495df4f850b143d5aa | |
| ToppCell | facs-GAT-Fat-3m-Epithelial|GAT / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.89e-04 | 181 | 70 | 4 | 11cb84528f7ca084f0a92eda4f2e18e63a428fe9 | |
| ToppCell | facs-GAT-Fat-3m-Epithelial-nan|GAT / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.89e-04 | 181 | 70 | 4 | 5ffeca29e4d31a20c110d27af128ed024a79ad56 | |
| ToppCell | Somatosensory_Cortex_(S1)-Neuronal-Inh_GABAergic-i_Gaba_2-GABA_VIP_1|Somatosensory_Cortex_(S1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.93e-04 | 182 | 70 | 4 | 7dc61e901428cea04f00ebb0939a44d21a6145c6 | |
| ToppCell | droplet-Lung-30m-Endothelial-arterial_endothelial-pulmonary_artery_endothelial_cell-pulmonary_artery_endothelial_cell_l25|30m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.97e-04 | 183 | 70 | 4 | 6f8f997ffc9eaebca2683de125b6069d07c07d26 | |
| ToppCell | TCGA-Thryoid-Primary_Tumor-Thyroid_Papillary_Carcinoma-Classical-1|TCGA-Thryoid / Sample_Type by Project: Shred V9 | 1.97e-04 | 183 | 70 | 4 | 06e4b05d86a7d643569e19575c2c9aa351d33f29 | |
| ToppCell | LPS_only-Stromal_mesenchymal-Lung_smooth_muscle-MatrixFB_->_Myofibroblast|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.97e-04 | 183 | 70 | 4 | 12daaea821e49bc94a01e2496331e92a80d27339 | |
| ToppCell | Somatosensory_Cortex_(S1)-Neuronal-Inh_GABAergic-i_Gaba_2-GABA_VIP_1-Inh_L1_ADARB2_ADAM33|Somatosensory_Cortex_(S1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.97e-04 | 183 | 70 | 4 | 5e361be3ae3fe05098968e58427630127bd12675 | |
| ToppCell | droplet-Marrow-nan-3m|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.01e-04 | 184 | 70 | 4 | 1154a5ad7b8512272b7476f949ddac350910bfb7 | |
| ToppCell | Anterior_Cingulate_gyrus_(CgG)-Neuronal-Inh_GABAergic-i_Gaba_2-GABA_VIP_1-Inh_L1_ADARB2_ADAM33|Anterior_Cingulate_gyrus_(CgG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 2.05e-04 | 185 | 70 | 4 | 487fa382232564f075960899d50afa0edae5d258 | |
| ToppCell | LPS-IL1RA-Epithelial_alveolar-AT_2|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.05e-04 | 185 | 70 | 4 | fefaf227d89f680d6f3e91c4a94e26ab4d0dc6c3 | |
| ToppCell | LPS-IL1RA-Epithelial_alveolar-AT_2-AT2_Progenitor|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.05e-04 | 185 | 70 | 4 | 929b68b05b7686341329ac756d7df172cb4b810b | |
| ToppCell | COVID-19-Epithelial_cells-Airway_ciliated|COVID-19 / group, cell type (main and fine annotations) | 2.05e-04 | 185 | 70 | 4 | 18a40f0a338aa398d81384b5159fb80ce8a2020c | |
| ToppCell | droplet-Heart-nan-3m-Endothelial|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.10e-04 | 186 | 70 | 4 | 0ae5fbe9f210cb25092394267e1d3d6ed05627b8 | |
| ToppCell | LPS-IL1RA+antiTNF-Epithelial_alveolar-AT_2-Differentiating_AT2|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.10e-04 | 186 | 70 | 4 | e83718fabb057100835d3357df407f283d23fe16 | |
| ToppCell | facs-Lung-EPCAM-3m-Epithelial-Ciliated_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.14e-04 | 187 | 70 | 4 | 04dba2ed09ee4180830bdf0191921696697ea234 | |
| ToppCell | PND03|World / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 2.14e-04 | 187 | 70 | 4 | b3fcb36d853adfdea7172c5591de06f027e50af3 | |
| ToppCell | COPD-Epithelial-Ciliated|COPD / Disease state, Lineage and Cell class | 2.14e-04 | 187 | 70 | 4 | f0fd0792f6926f705d175f6e6fd480f12c7a3bd4 | |
| ToppCell | Control-Fibroblasts-Alveolar_FB|Control / group, cell type (main and fine annotations) | 2.14e-04 | 187 | 70 | 4 | 92d468dde81125d51daf7abd4703741abe1ab91c | |
| ToppCell | facs-Lung-EPCAM-3m-Epithelial-ciliated_columnar_cell_of_tracheobronchial_tree|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.14e-04 | 187 | 70 | 4 | 805dafe22f835ece4dd091d8030d0a63b52a48dd | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Neuronal-Inh_GABAergic-i_Gaba_2-GABA_VIP_1-Inh_L1_ADARB2_ADAM33|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 2.14e-04 | 187 | 70 | 4 | 02105c82a9ba79d2f19e002188377fc3440770c2 | |
| ToppCell | facs-Heart-RA-3m-Endothelial-endocardial_cell|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.18e-04 | 188 | 70 | 4 | 4ddb11a90bf3baa7237bde304db44dfcc56aed52 | |
| ToppCell | facs-Heart-RA-3m-Endothelial-endothelial_cell_of_endocardium|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.18e-04 | 188 | 70 | 4 | e47e66906922d5c69b1aafe28face0787d3fc563 | |
| ToppCell | ASK454-Epithelial-Type_1|ASK454 / Donor, Lineage and Cell class of Lung cells from Dropseq | 2.18e-04 | 188 | 70 | 4 | 13f8ce8f24ac7d7ed87f4ae3b8f4096de29383c2 | |
| ToppCell | TCGA-Colorectal-Primary_Tumor-Colorectal_Adenocarcinoma-Colon_Adenocarcinoma-7|TCGA-Colorectal / Sample_Type by Project: Shred V9 | 2.18e-04 | 188 | 70 | 4 | 14bc73cf79c79c9f208369fd8d498e5b26e0114d | |
| ToppCell | COVID-19_Moderate-NK_activated|COVID-19_Moderate / disease group, cell group and cell class | 2.23e-04 | 189 | 70 | 4 | 8f9f1e71857bed6d59c4b087b6a6970f30fd86be | |
| ToppCell | Entopeduncular-Macroglia-POLYDENDROCYTE-P1-P1_2|Entopeduncular / BrainAtlas - Mouse McCarroll V32 | 2.25e-04 | 75 | 70 | 3 | 9a82db6281326acc534b800e02b262a8617a147e | |
| ToppCell | Entopeduncular-Macroglia-POLYDENDROCYTE-P1-P1_2-Tnr-Polydendrocyte.Tnr.Pdgfa_(Pdgfa)|Entopeduncular / BrainAtlas - Mouse McCarroll V32 | 2.25e-04 | 75 | 70 | 3 | 7678e7d514560c774b56fc0a20312d561c89f587 | |
| ToppCell | Entopeduncular-Macroglia-POLYDENDROCYTE-P1-P1_2-Tnr|Entopeduncular / BrainAtlas - Mouse McCarroll V32 | 2.25e-04 | 75 | 70 | 3 | 7f1fc575fca42352434f7188c7a95b50372aeefa | |
| ToppCell | Somatosensory_Cortex_(S1)-Neuronal-Inh_GABAergic-i_Gaba_1-GABA_L1_LAMP5|Somatosensory_Cortex_(S1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 2.27e-04 | 190 | 70 | 4 | 56cc761e50fddfb5366391518b4d8e16589b6b42 | |
| ToppCell | Somatosensory_Cortex_(S1)-Neuronal-Inh_GABAergic-i_Gaba_1|Somatosensory_Cortex_(S1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 2.27e-04 | 190 | 70 | 4 | 25d4b591f75c26e404a34c42f1742d580af6598d | |
| ToppCell | (5)_Fibroblasts-(5)_Fibroblast-C_(Myofibroblast)|(5)_Fibroblasts / Lung cell shreds - cell class (v4) and cell subclass (v4) | 2.27e-04 | 190 | 70 | 4 | 71e112dfb8c3190fe0286b45a046ea789eb6a8db | |
| ToppCell | PCW_07-8.5-Mesenchymal-Mesenchymal_fibroblastic-mes_immature_COL13A1^pos_fibro1_(4)|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung | 2.32e-04 | 191 | 70 | 4 | fa380a8752de158974b2ae5e741573439719cc0d | |
| ToppCell | droplet-Kidney-KIDNEY-1m-Epithelial-Pecam____Kidney_cortex_artery_cell|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.32e-04 | 191 | 70 | 4 | b9ae5af426e7a1f2652a47700bb168371bd2dec6 | |
| ToppCell | nucseq-Mesenchymal-Fibroblastic-Fibroblastic_2-AF1|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 2.32e-04 | 191 | 70 | 4 | 6688cee34beee4f151ac17fccbc9c26a9aad72e1 | |
| ToppCell | nucseq-Mesenchymal-Fibroblastic-Fibroblastic_2|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 2.36e-04 | 192 | 70 | 4 | 99ce9e3c4c50cf64ebb62145f2b5420efa0db309 | |
| ToppCell | Adult-Mesenchymal-matrix_fibroblast_2_cell|Adult / Lineage, Cell type, age group and donor | 2.36e-04 | 192 | 70 | 4 | d21f0f577156f17c899b08871046a26b88aea011 | |
| ToppCell | IPF-Epithelial-Ciliated|World / Disease state, Lineage and Cell class | 2.36e-04 | 192 | 70 | 4 | d903bbd6c18e29e2c4cdedeb3fea1fd5ad7baa11 | |
| ToppCell | COPD-Epithelial-Ciliated|World / Disease state, Lineage and Cell class | 2.36e-04 | 192 | 70 | 4 | eab1105cd1a98cfcd3d74dc5c9b89e1799bba59e | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Neuronal-Inh_GABAergic|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 2.36e-04 | 192 | 70 | 4 | bf1943715085c4124b1675888b0615c9500ec888 | |
| ToppCell | IPF-Epithelial-Ciliated|IPF / Disease state, Lineage and Cell class | 2.36e-04 | 192 | 70 | 4 | 354adc1354bf596fbc60dd45c0169688e6f45165 | |
| ToppCell | COPD-Stromal-Myofibroblast|Stromal / Disease state, Lineage and Cell class | 2.36e-04 | 192 | 70 | 4 | 62904f94dfce430456f05066522cbf9bd29f4d7e | |
| ToppCell | IPF-Epithelial-Ciliated|Epithelial / Disease state, Lineage and Cell class | 2.41e-04 | 193 | 70 | 4 | ad58f5080e0ba65c845056ea6b79037b636e9c64 | |
| ToppCell | Children_(3_yrs)-Mesenchymal-matrix_fibroblast_1_cell|Children_(3_yrs) / Lineage, Cell type, age group and donor | 2.41e-04 | 193 | 70 | 4 | 99525545552b371c86b18b6ea6f4897dc6e9a9ec | |
| ToppCell | Control-Stromal-Myofibroblast|Stromal / Disease state, Lineage and Cell class | 2.41e-04 | 193 | 70 | 4 | 5896242f713ae5fd1a4ebb63827f15d7279dced2 | |
| ToppCell | Smart-start-Cell-Wel_seq-Neoplastic-Differentiated-like-MES-like-MES-like_hypoxia_independent-G|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 2.46e-04 | 194 | 70 | 4 | f44394c8a6f86483063f2f5722f003a8a0a70254 | |
| ToppCell | Control-Epithelial-Ciliated|World / Disease state, Lineage and Cell class | 2.46e-04 | 194 | 70 | 4 | 958e648138676d46698090b4046cb484083ae449 | |
| ToppCell | Differ-Basal|World / shred by cell class for mouse tongue | 2.46e-04 | 194 | 70 | 4 | 851eff82c9f3d44c86e3e127a804bbd1fced6a7c | |
| ToppCell | IPF-Multiplet-Multiplet|IPF / Disease state, Lineage and Cell class | 2.51e-04 | 195 | 70 | 4 | fce0c29574bb7aab181b9c00feb42681e285d1f2 | |
| ToppCell | IPF-Multiplet-Multiplet|World / Disease state, Lineage and Cell class | 2.51e-04 | 195 | 70 | 4 | 21dbdc803c6947024dc2416e9e21c2ef0af9bc31 | |
| ToppCell | COVID-19-Fibroblasts-Alveolar_FB|COVID-19 / group, cell type (main and fine annotations) | 2.51e-04 | 195 | 70 | 4 | 603050beeb33c331d4b2e3fa46cae3f3e0e4bdc7 | |
| ToppCell | IPF-Multiplet|IPF / Disease state, Lineage and Cell class | 2.51e-04 | 195 | 70 | 4 | eacc0449ae6f3ad8002268cd061467684c6fb9a7 | |
| ToppCell | saliva-Mild-Moderate_progression_d12-25-Myeloid-Granulocytic-Neutrophil|Mild-Moderate_progression_d12-25 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 2.56e-04 | 196 | 70 | 4 | fe8d3f45a64323947c36b127355d5940eb56c0ca | |
| ToppCell | COPD-Multiplet-Multiplet|COPD / Disease state, Lineage and Cell class | 2.56e-04 | 196 | 70 | 4 | af4cdc61830685a888a1209826c23bcf54a43084 | |
| ToppCell | facs-Skin-Telogen-3m-Epithelial-outer_bulge|Skin / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.56e-04 | 196 | 70 | 4 | c936014125b2ed5f796221b74acb77b8f8359875 | |
| ToppCell | Somatosensory_Cortex_(S1)-Neuronal-Inh_GABAergic|Somatosensory_Cortex_(S1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 2.56e-04 | 196 | 70 | 4 | 7af6c5147ac859353504d19727dbe24f63a29dd4 | |
| ToppCell | COPD-Multiplet|COPD / Disease state, Lineage and Cell class | 2.56e-04 | 196 | 70 | 4 | 6d02d494196e3f857d53eea46d9419690d43beca | |
| ToppCell | saliva-Mild-Moderate_progression_d12-25-Myeloid-Granulocytic|Mild-Moderate_progression_d12-25 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 2.56e-04 | 196 | 70 | 4 | 526d037bb12d81f1c235c60ddc787fbad0bbad77 | |
| ToppCell | IPF-Epithelial|IPF / Disease state, Lineage and Cell class | 2.56e-04 | 196 | 70 | 4 | 87d9881cfec461a5d89b688a83749b618c519485 | |
| ToppCell | PCW_13-14-Mesenchymal-Mesenchymal_fibroblastic-mes_immature3_(17)|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung | 2.61e-04 | 197 | 70 | 4 | 31a1852911bda38543916585fda34255fd62a134 | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Mesenchymal-Fibroblast-Collagen+matrisome-high_fibroblast-|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 2.61e-04 | 197 | 70 | 4 | 85a8f1d18e0dd1d31341f5131eecd217553bf042 | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Mesenchymal-Fibroblast-Collagen+matrisome-high_fibroblast|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 2.61e-04 | 197 | 70 | 4 | e8e3ba791dfaa0fab35e0329a5e34376f9ee6143 | |
| ToppCell | BL|World / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 2.61e-04 | 197 | 70 | 4 | 1acf0191fa0a25cd20bfd9ea7bf727a1555986a1 | |
| ToppCell | ASK440-Epithelial-Type_1|ASK440 / Donor, Lineage and Cell class of Lung cells from Dropseq | 2.61e-04 | 197 | 70 | 4 | 1eda2c2504451a3d626dda5c2b2b12eeaa6bca54 | |
| ToppCell | ASK440-Epithelial-Type_1|Epithelial / Donor, Lineage and Cell class of Lung cells from Dropseq | 2.61e-04 | 197 | 70 | 4 | 782449c522c9e16e72bf999a73090688a3aefe06 | |
| ToppCell | ASK428-Epithelial-Type_1|ASK428 / Donor, Lineage and Cell class of Lung cells from Dropseq | 2.61e-04 | 197 | 70 | 4 | 9ae6661c307791c3f0ecd3d378e3d917565e5498 | |
| Drug | pyrimidine-2,4-dione | 2.77e-07 | 5 | 70 | 3 | CID000150747 | |
| Drug | gamma-Glu-Gly | 5.01e-06 | 37 | 70 | 4 | CID000100099 | |
| Drug | AC1L1K9N | 7.79e-06 | 13 | 70 | 3 | CID000005398 | |
| Disease | attempted suicide | 5.79e-05 | 178 | 68 | 5 | EFO_0004321 | |
| Disease | Intellectual Disability | 7.64e-05 | 447 | 68 | 7 | C3714756 | |
| Disease | Colorectal Carcinoma | 1.15e-03 | 702 | 68 | 7 | C0009402 | |
| Disease | response to angiotensin receptor blocker | 2.18e-03 | 30 | 68 | 2 | EFO_0010735 | |
| Disease | Parkinsonian Disorders | 2.18e-03 | 30 | 68 | 2 | C0242422 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| NEKNRPKDWSEVTIW | 206 | Q6PI77 | |
| DWQNTDKAVNWLRKE | 176 | Q6UWY0 | |
| WEFWNLKTLQEREAR | 2196 | Q96L91 | |
| KWNWRTKPQSRDFDE | 211 | Q49A92 | |
| PVQKDSREENWQEWR | 101 | Q5VSY0 | |
| ISQKQELWREKWERH | 216 | P58397 | |
| HKLTKEQWEERIQNW | 161 | P35241 | |
| EKEALKRRWRWQQTQ | 226 | Q6GQQ9 | |
| VWTNQRVLKWVRDID | 611 | Q674X7 | |
| VSQWWERLTKQEKRP | 86 | Q9P035 | |
| HRIWQKLRAEEQTWQ | 311 | Q9H3C7 | |
| NNEVQLEFRKSWERW | 406 | P43220 | |
| WSLEERKREQWNSLK | 201 | Q8TC71 | |
| FRNSTAKWWKREIEE | 1386 | O43451 | |
| ETARKSQWKKWEVVA | 1031 | P54098 | |
| DNERKEWESQWKIMQ | 26 | Q6ZU52 | |
| SRWVWDQEEERKRQE | 1221 | Q8WWI1 | |
| HKLNKDQWEERIQVW | 161 | P26038 | |
| QEEKMWRQEEKIQEW | 286 | A8MZA4 | |
| WRQEEKIQEWEEKIQ | 291 | A8MZA4 | |
| TEWKRQNITNQLEKW | 251 | Q68CQ7 | |
| RWQQTQQNKEEEWER | 251 | Q8TE49 | |
| PAAAEQWRKWQRDKE | 2901 | O95613 | |
| ESWRKKWNVICNRSI | 271 | Q68CR7 | |
| DRKWGQIQKWLEDSE | 66 | Q9Y608 | |
| NWKKIQEELNSRWER | 4546 | Q9UPN3 | |
| EVQAEIKRKWRSWKV | 406 | P41586 | |
| LKAEEWPWNRKNRQI | 786 | Q8N475 | |
| NRTTAVKQWEQRWIK | 811 | Q9Y2X0 | |
| VKQWEQRWIKNCLAV | 816 | Q9Y2X0 | |
| VKRWIADVETKRWQS | 396 | Q9UII4 | |
| WKVSRNWREIVVQDK | 526 | Q4G163 | |
| LDRMCEDLWRWQKQN | 326 | Q14376 | |
| FKTWWIDGVQEQVRK | 366 | Q9HDB9 | |
| LRWKKEQTHWRQANE | 1396 | Q8NF50 | |
| RWIWSRESQKEVEKE | 41 | Q96BQ5 | |
| WWIAKQRGKRAITDN | 46 | Q9H336 | |
| TANWREKWSKVRAER | 101 | Q96A19 | |
| NQLREKWEKERSWHQ | 856 | Q9BV73 | |
| EIKEVHKRWWQLRDN | 3071 | Q99698 | |
| KWWDNINVQKRAAVR | 221 | P49641 | |
| EEKVEVWFKNRRAKW | 201 | P56915 | |
| LDDRKQWWKVRNASG | 561 | Q12929 | |
| QENNRLEILKRKWWE | 771 | Q16099 | |
| VWNNEHVKTDWDRAK | 576 | Q8NBJ5 | |
| ENNRLEILKRKWWEG | 771 | Q16478 | |
| TDNRRSIKWRELDQW | 471 | Q9NZJ4 | |
| NWREKWSKVRAERNS | 101 | Q68D86 | |
| IDWDQIREEGLKWQK | 171 | Q9NXZ2 | |
| WIQQVDQSWRKERVL | 116 | P15328 | |
| QGWWDEEQEKAWRKQ | 371 | P12694 | |
| RKVIIWREENGTWEK | 81 | P55735 | |
| REAFLREVWQWKEAK | 211 | Q5ST30 | |
| FWNLWRSQIEQKKER | 421 | A8K8P3 | |
| RQWVIQEFKLWDNEL | 206 | P49354 | |
| KETRWQKWQNKDDQG | 441 | Q9BVG9 | |
| QWEKPKEWLEREQRQ | 156 | Q9BTA9 | |
| WLVSQKEWERERAFQ | 896 | Q7Z745 | |
| QWLRAELEAREKLWQ | 1986 | Q9NRC6 | |
| QQNKEDAWIEHDVWR | 201 | Q9UHE8 | |
| KIRENNNISREEWEW | 641 | Q8N957 | |
| VWQWDEKWTQLRIRK | 396 | Q7KZ85 | |
| WRDQLSKRSIQWEER | 276 | Q6FHJ7 | |
| RARKRQAWLWEEDKN | 376 | P54274 | |
| QDVTREWAKKVVWKR | 76 | Q02763 | |
| EAKRKIRQWEESWQQ | 576 | Q9H9P5 | |
| VNAWKHWVKTRQLDE | 1076 | Q9UBW7 | |
| RASWKSNRWPQENKE | 431 | Q8N3Z6 | |
| VLKWIRENISEWRNC | 151 | P60891 | |
| TILLWEWNVERNKVK | 166 | Q9GZL7 | |
| NWKEIVESCDLKNWR | 636 | O94979 | |
| QEQRRDQKWRWQLEE | 866 | Q07283 | |
| EDEKKSGQWWRQLLA | 186 | Q6NUK1 | |
| KIARWEEWNKRLEEV | 651 | Q96M32 |